相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Substrate specificity of human matriptase-2
M. Wysocka et al.
BIOCHIMIE (2014)
A new proteinase 3 substrate with improved selectivity over human neutrophil elastase
J. Popow-Stellmaszyk et al.
ANALYTICAL BIOCHEMISTRY (2013)
Drug Combinations with Proteasome Inhibitors in Antitumor Therapy
Laura Gatti et al.
CURRENT PHARMACEUTICAL DESIGN (2013)
Carfilzomib: A new proteasome inhibitor for relapsed or refractory multiple myeloma
Jason M Steele
JOURNAL OF ONCOLOGY PHARMACY PRACTICE (2013)
Three Wavelength Substrate System of Neutrophil Serine Proteinases
Magdalena Wysocka et al.
ANALYTICAL CHEMISTRY (2012)
Pegylated Fluorescent Peptides as Substrates of Proteolytic Enzymes
Magdalena Wysocka et al.
PROTEIN AND PEPTIDE LETTERS (2012)
Highly Specific Substrates of Proteinase 3 Containing 3-(2-Benzoxazol-5-yl)-L-alanine and Their Application for Detection of This Enzyme in Human Serum
Magdalena Wysocka et al.
ANALYTICAL CHEMISTRY (2010)
Optimization of a series of dipeptides with a P3 threonine residue as non-covalent inhibitors of the chymotrypsin-like activity of the human 20S proteasome
Christopher Blackburn et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
NMR-Guided Molecular Docking of a Protein-Peptide Complex Based on Ant Colony Optimization
Oliver Korb et al.
CHEMMEDCHEM (2010)
Simultaneous Fluorescent Monitoring of Proteasomal Subunit Catalysis
Aya Wakata et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2010)
Chemical Tools To Study the Proteasome
Martijn Verdoes et al.
EUROPEAN JOURNAL OF ORGANIC CHEMISTRY (2009)
Limitations of SLLVY-AMC in calpain and proteasome measurements
Christopher J. Giguere et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Assessment of circulating proteasome chymotrypsin-like activity in plasma of patients with acute and chronic leukemias
Halina Ostrowska et al.
CLINICAL BIOCHEMISTRY (2008)
Immunological methods to quantify and characterize proteasome complexes: Development and application
Matthias Majetschak et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2008)
Potent activity of carfilzomib, a novel, irreversible inhibitor of the ubiquitin-proteasome pathway, against preclinical models of multiple myelorna
Deborah J. Kuhn et al.
BLOOD (2007)
Extracellular proteasome in the human alveolar space: a new housekeeping enzyme?
Stephan Urs Sixt et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2007)
Circulating proteasome levels are an independent prognostic factor for survival in multiple myeloma
Christian Jakob et al.
BLOOD (2007)
High plasma proteasome levels are detected in patients with metastatic malignant melanoma
PE Stoebner et al.
BRITISH JOURNAL OF DERMATOLOGY (2005)
Degradation-mediated protein quality control in the nucleus
RG Gardner et al.
CELL (2005)
The ubiquitin system for protein degradation and some of its roles in the control of the cell division cycle
A Hershko
CELL DEATH AND DIFFERENTIATION (2005)
Intracellular protein degradation: from a vague idea thru the lysosome and the ubiquitin-proteasome system and onto human diseases and drug targeting
A Ciechanover
CELL DEATH AND DIFFERENTIATION (2005)
Inhibitors of the eukaryotic 20S proteasome core particle: a structural approach
M Groll et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2004)
Proteasomes and Molecular Chaperones Cellular Machinery Responsible for Folding and Destruction of Unfolded Proteins
Jun Imai et al.
CELL CYCLE (2003)
The structure of the mammalian 20S proteasome at 2.75 Å resolution
M Unno et al.
STRUCTURE (2002)
Development and evaluation of a sandwich ELISA for quantification of the 20S proteasome in human plasma
D Dutaud et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2002)
Rapid degradation of a large fraction of newly synthesized proteins by proteasomes
U Schubert et al.
NATURE (2000)
分享论文
